Form 4 holding
VP, Clinical Dev & Med Affairs
Zosano Pharma Corp
- Security class
- Common Stock
- Shares / value
- 56,331
- Estimated value
- Report date
- 31 Mar 2022
- Price
- Ownership
- Direct
Donald J. Kellerman
Insider Reports History
- Reporting-owner location
- Durham, NC
- Latest reporting-owner signature
-
/s/ Steven Lo, Attorney-in-Fact for Donald J. Kellerman
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Donald J. Kellerman
Insider Reports Filed by Donald J. Kellerman
4
Zosano Pharma Corp
- Report period
- 31 Mar 2022
- Transactions
- 1
- Transaction value
- -$842
- Accepted by SEC
- 01 Apr 2022, 21:08
- Role
- VP, Clinical Dev & Med Affairs
- Next action
- Open filing details
4
Zosano Pharma Corp
- Report period
- 15 Oct 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 19 Oct 2021, 21:36
- Role
- VP, Clinical Dev & Med Affairs
- Next action
- Open filing details
4
Zosano Pharma Corp
- Report period
- 04 Jun 2021
- Transactions
- 1
- Transaction value
- -$1,376
- Accepted by SEC
- 07 Jun 2021, 18:42
- Role
- VP, Clinical Dev & Med Affairs
- Next action
- Open filing details